Digitalization

How can Life Science Technology Providers Support the Pharmaceutical Industry in the Transition Toward More Digitally Connected Operations?

Pharma's Almanac

Investment

What are the Current Investment Trends in the Pharmaceutical Industry, and How are They Influencing the Sector’s Direction?

Pharma's Almanac

3D Printing

Exploring New Possibilities with 3D Printing of Pharmaceuticals

Thomas Kipping, Ph.D.

MilliporeSigma

Roundtable

What do you see as the most significant regulatory decision or guidance on the horizon for 2024 (or beyond)?

Pharma's Almanac

Viscosity Reduction

Viscosity Reduction with An Excipient Platform and Feasibility Testing Service

Alana Gouveia

MilliporeSigma

Alternative Excipient

Preparing Today for a Potential Ban on Titanium Dioxide in Pharmaceutical Drug Products

Almut von der Brelie

MilliporeSigma

Roundtable: Artificial Intelligence

In what areas of pharma/biopharma are you most excited to see increased adoption of artificial intelligence (AI) and machine learning?

Pharma's Almanac

API

Enhanced Solubility through API Processing: Salt and Cocrystal Formation

Thomas Briel, Ph.D.; David Luedeker, Ph.D.

MilliporeSigma

International Markets

In what international markets do you anticipate significant developments in the near future?

Pharma's Almanac

Disruptive Technology

What do you view as the most disruptive or transformational technology or development on the horizon?

Pharma's Almanac

3D Printing

Advancing Extrusion-Based 3D Printing for Drug Production

Thomas Kipping, Ph.D.; Xianghao Zuo, Ph.D.

MilliporeSigma

Sweeteners

High-Intensity Sweeteners for Taste Optimization

Almut von der Brelie

MilliporeSigma

Sustainability

What is your plan to build a more sustainable business practice in the coming years?

Pharma's Almanac

Real-Time Monitoring

Raman Spectroscopy as a PAT Tool Advancing Biopharma Manufacturing

Stacy Shollenberger

MilliporeSigma

Manufacturing Investment

MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France

MilliporeSigma

Lipid Excipients

Regulatory Considerations for Lipid Excipients

Claudia Widmann; Estelle Beguin Ph.D.

MilliporeSigma

Excipient Quality Assurance

Assuring Excipient Quality for Parenteral Products

Lars Albermann, Ph.D.; Markus Greulich

MilliporeSigma

Biomanufacturing

Optimizing Fed-Batch Processes with Chemically Defined Media and Feeds

Jonathan Kaiser

MilliporeSigma

Unmet Needs

In which orphan spaces or unmet medical needs do you think we will see the next treatment innovations?

Pharma's Almanac

Industry Challenges

What do you consider the biggest challenge that the pharma/biopharma industry currently faces?

Pharma's Almanac